Christopher Wolfe, OD
speaker
205 appearances
1 recordings
1 series
first heard May 2026
last heard 18 May
Christopher Wolfe, OD’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in May 2026 with 1.
Appearances
EyeCode Media · The Chris Wolfe Podcast: All Things Caratenoids w/ Kirsten Ormsby · 18 May 2026
podcast
You're saying, so when, when you, so all,
the addition in patients who cannot convert lutein to mesozeaxanthine, the supplementation of mesozeaxanthine increased their lutein content as well.
That's what you're saying.
So that's the 10, 10, two formula.
Yeah.
Settles the nerves.
Yeah, that's the case you made.
Yeah, help us with that conversation with the patient.
I mean, I think what's
What I'd like to get your reaction to is, and we were talking to Frederick this morning about a lot of these issues in terms of how do we get beyond AREDS?
How do we get beyond macular degeneration?
So I think one of the things that I think is compelling about the discussion is the conversion, right?
So that's why we need the specific ratio.
And just as a kind of a reflection, I remember when I got out of school, when people were measuring MPOD a lot in the, you know,
With an, I'm going to draw a blank on the device name.
Yes.
And, um, and I had a colleague who was noticing that, you know, he's like, I don't think a lot of people absorb this.
And so what he was adding was a CoQ10.
Are you familiar with that practice?
So he, he thought that that was, was able to help people, um, convert.
Showing 81–100 of 205 · page 5 of 11
← Previous
Next →